Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
about
Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse eventsCationic amino acid transporter-2 regulates immunity by modulating arginase activity.Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flowThe multifaceted role of pirfenidone and its novel targets.Allograft inflammatory factor-1 and its immune regulation.Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses.Current and future anti-fibrotic therapies for chronic liver disease.Arginase: an emerging key player in the mammalian immune system.Fibrogenesis in kidney transplantation: potential targets for prevention and therapy.Role of arginase in asthma: potential clinical applications.IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe.Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?Arginase inhibition prevents bleomycin-induced pulmonary hypertension, vascular remodeling, and collagen deposition in neonatal rat lungs.Arginase and arginine dysregulation in asthma.Update on Chronic Lung Allograft Dysfunction.Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection.Single- and multiple-dose pharmacokinetics of pirfenidone, an antifibrotic agent, in healthy Chinese volunteers.Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies.Tissue metabolic changes for effects of pirfenidone in rats of acute paraquat poisoning by GC-MS.
P2860
Q26824810-AF61817E-C0E9-416F-8F35-DFB8C26DDE9AQ33325920-87CC301A-F891-430D-93DF-DAF446C95E28Q33889591-6604BD9B-0E1E-4317-9ECF-FEDBDBDAD667Q34623073-0A52DA06-FDBA-4F6D-833F-A595E8C9A0A4Q36799403-0F9BDE7C-F481-40BD-A7A6-7B234748AA1AQ37305376-44BBB6C8-383E-438F-85F5-1168792B30BEQ37317654-64A51E54-9232-4758-B156-48C256AF2B45Q37395887-918CC3EF-C283-41DC-8551-3F61701E0E81Q37638064-5A6E07B2-7782-43A5-80E7-2A7B7D7E1C67Q37960068-646CF118-F623-456E-A693-31C6CA9DC219Q38359491-CD51A2A0-D30D-41A4-A1C7-307EF873D4D6Q38932342-D0FA07D4-73F0-4E2A-961A-FD65B9148890Q40410213-2E1D6ED5-CB0F-4A2A-A3C7-FD807EB28895Q41557551-D93B52E4-F543-4BF9-A265-A7A8FC491775Q41572196-E4489A1A-C5FE-47CA-8659-9A3EFA01C968Q41831572-E0E6CDB8-8CE2-4FEA-BCD6-81B498230BE5Q41975571-2725EA6B-46C2-4508-A64F-01EBC78A3343Q42246110-C54BF016-48E6-4EC0-8B46-734E0FD3AA23Q46974104-3A2D3404-DBED-451F-A6F7-D5C626372351Q47901631-645F6104-8DD1-46EF-BCC4-88AEAD8B8608Q49602271-9B2C8E07-A1BC-42FE-B6C1-D3CEF5B8D531
P2860
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
description
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Juni 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/06/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/06/01)
@nl
наукова стаття, опублікована в червні 2005
@uk
مقالة علمية (نشرت في يونيو 2005)
@ar
name
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
@ast
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
@en
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
@nl
type
label
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
@ast
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
@en
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
@nl
prefLabel
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
@ast
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
@en
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
@nl
P2093
P2860
P1476
Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway
@en
P2093
Andrew C. Gaugler
Gary A. Visner
Hanzhong Liu
Peter Drew
Yanping Cheng
P2860
P304
P356
10.1111/J.1600-6143.2005.00876.X
P407
P577
2005-06-01T00:00:00Z